Showing results (61-70 of 103) with videos related to
Sort By:
Pageof 11
The British Journal of Ophthalmology|January 22, 2002
Quality of life and systemic comorbidities in patients with ophthalmic diseaseMelissa M Brown, Gary C Brown, Sanjay Sharma, et al.Current Opinion in Ophthalmology|April 5, 2011
Healthcare costs, buyer alertMelissa M Brown, Gary C Brown, Heidi B Leiske, et al.American Journal of Ophthalmology|February 28, 2002
A cost-utility analysis of interventions for severe proliferative vitreoretinopathyGary C Brown, Melissa M Brown, Sanjay Sharma, et al.Ophthalmology|February 26, 2018
Vision-Related Quality of Life Associated with Unilateral and Bilateral Ocular ConditionsGary C Brown, Melissa M Brown, Joshua D Stein, et al.Cornea|September 25, 2008
The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconusRichard H Roe, Jonathan H Lass, Gary C Brown, et al.Ophthalmic Epidemiology|January 30, 2002
Incremental cost-effectiveness of laser therapy for visual loss secondary to branch retinal vein occlusionGary C Brown, Melissa M Brown, Sanjay Sharma, et al.Ophthalmology|July 23, 2017
Cost-Utility of Evaluation for Posterior Vitreous Detachment and Prophylaxis of Retinal DetachmentNicolas A Yannuzzi, Jonathan S Chang, Gary C Brown, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|April 6, 2002
Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degenerationMelissa M Brown, Gary C Brown, Sanjay Sharma, et al.Eclinicalmedicine|December 28, 2023
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 studyArshad M Khanani, David S Boyer, Charles C Wykoff, et al.Transactions of the American Ophthalmological Society|April 23, 2008
The goal of value-based medicine analyses: comparability. The case for neovascular macular degenerationGary C Brown, Melissa M Brown, Heidi C Brown, et al.Pageof 11